In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Jean-François SpinellaInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0009-0005-6279-1543 Jalila ChagraouiInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Céline MoisonInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0009-0008-5381-3546 Isabel BoivinInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0002-1216-3240 Guillaume Richard CarpentierPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0001-6452-8814 Nadine MayotteInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0003-1739-3106 François BéliveauLeukemia Cell Bank of Quebec, Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.ORCID 0000-0001-6324-2363 Vincent P LavalléeInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0001-9095-0066 Josée HébertInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0002-2267-1353 Guy SauvageauInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0002-4333-7266 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
HSP90 Heat-Shock ProteinsLeukemia, Myeloid, AcuteMutationProtein BiosynthesisRibosomal ProteinsRibosomesTumor Suppressor Protein p53HumansHSP90 Heat-Shock ProteinsRibosomal ProteinsTP53 protein, humanTumor Suppressor Protein p53
Identifiers
PMID42139355
PMCPMC13178563
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390